📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-13 18:04
0 analysed today
0
Today
136,516
All-time analysed
40,455
Positive
6,317
Negative
81,811
Neutral
7,865
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
3 announcements match the current filters (relevance ≥ 5).
46% YoY Revenue Growth in Q1 FY27; PAT up 151% QoQ to ₹1.42 Cr
Aayush Wellness reported a strong Q1 FY27 with consolidated revenue rising 46.3% YoY to ₹33.11 crore. Profit After Tax (PAT) grew 22.6% YoY to ₹1.42 crore, showing a significant sequential recovery of 150.8% compared to Q4 FY26. Earnings Per Share (EPS) improved to ₹0.29 from ₹0.24 in the year-ago period. The growth was driven by digital commerce scaling and improved distribution efficiency across its preventive healthcare portfolio.
Confidence: HIGH
What changedThe company has transitioned from a period of lower sequential profitability to a sharp recovery in Q1 FY27 while maintaining high double-digit revenue growth.
Why it mattersFor a micro-cap company with a ₹108 crore market cap, demonstrating scalable profitability is essential to support its current valuation (P/B of 9.0) and offset risks associated with zero promoter holding.
Q1 FY27 Revenue: ₹33.11 croreYoY Revenue Growth: 46.3%Q1 FY27 PAT: ₹1.42 croreQoQ PAT Growth: 150.8%Q1 Revenue vs TTM Revenue: 21.4%
📅 Short termThe sharp sequential profit rebound and strong YoY top-line growth are likely to be viewed positively by the market in the coming weeks.
📈 Long termStructural growth depends on the successful transition to a service-based model (wellness centers) and scaling international exports beyond the current Singapore concentration.
⚠ Risk flags
- Zero promoter holding (0.0%)
- Low historical operating margins (1.2% TTM)
- High client concentration in exports
Key Highlights
Consolidated Revenue from Operations reached ₹33.11 crore, a 46.3% increase over Q1 FY26.
Profit After Tax (PAT) surged 150.8% quarter-on-quarter to ₹1.42 crore.
Earnings Per Share (EPS) increased to ₹0.29 from ₹0.24 YoY and ₹0.12 QoQ.
Company is evaluating export opportunities in the Middle East (UAE) and South Asia to diversify revenue.
Operating leverage and cost discipline cited as primary drivers for the sharp sequential profit increase.
👀 What to Watch
Investors should monitor if the company can sustain these improved margins given the historically low TTM OPM of 1.2% and track the execution of the proposed ₹30 crore wellness tourism investment.
46% YoY Revenue Growth in Q1 FY27; PAT Rises to ₹1.42 Cr
Aayush Wellness reported a strong start to FY27 with consolidated revenue growing 46.3% YoY to ₹33.11 Cr. Profit After Tax (PAT) saw a significant sequential recovery, jumping 150.8% QoQ to ₹1.42 Cr from ₹0.56 Cr in the previous quarter. While YoY PAT growth was more modest at 22.6%, the company is showing signs of improved operating leverage. However, the business continues to operate with thin margins and a unique 0% promoter holding structure.
Confidence: HIGH
What changedThe company reported its Q1 FY27 financial results, marking a significant sequential turnaround in profitability and maintaining high double-digit revenue growth.
Why it mattersFor a micro-cap company with a ₹108 Cr market cap, the 46% revenue growth validates its aggressive scaling strategy, though the 0% promoter holding remains a structural point of note for risk assessment.
Consolidated Revenue (Q1 FY27): ₹33.11 CrConsolidated PAT (Q1 FY27): ₹1.42 CrYoY Revenue Growth: 46.3%QoQ PAT Growth: 150.8%Q1 Revenue vs TTM Revenue: 21.4%
📅 Short termThe sharp sequential profit recovery and strong top-line growth are likely to be viewed positively by the market in the coming weeks.
📈 Long termThe company is attempting to pivot from a product-only model to a service-oriented wellness platform; long-term value depends on margin expansion and successful diversification into herbal alternatives.
⚠ Risk flags
- 0.0% promoter holding
- Very low operating margins (TTM OPM 1.2%)
- High concentration in stock-in-trade purchases (outsourced model risk)
Key Highlights
Consolidated revenue from operations increased to ₹33.11 Cr, up 46.3% from ₹22.63 Cr in Q1 FY26.
Consolidated PAT reached ₹1.42 Cr, representing a 150.8% growth over the preceding quarter (Q4 FY26).
Earnings Per Share (EPS) improved to ₹0.29 for the quarter, compared to ₹0.24 in the year-ago period.
Standalone revenue stood at ₹24.07 Cr, contributing approximately 73% of the total consolidated top-line.
Total expenses for the standalone entity were ₹23.52 Cr, with stock-in-trade purchases accounting for nearly 98% of costs.
👀 What to Watch
Investors should monitor if the company can sustain the sequential profit growth and improve its thin operating margins (TTM OPM at 1.2%). Watch for updates on the ₹30 Cr wellness tourism investment and the execution of the $3M Singapore export order.
46% YoY Revenue Growth in Q1 FY27; Consolidated PAT Rises to Rs 1.42 Cr
Aayush Wellness reported a 46.3% YoY increase in consolidated revenue to Rs 33.11 Cr for Q1 FY27. Consolidated Profit After Tax (PAT) grew 22.6% YoY to Rs 1.42 Cr, while showing a significant 150.8% sequential (QoQ) recovery from Rs 0.56 Cr in Q4 FY26. The company attributes this growth to product portfolio expansion and digital commerce scale-up. However, standalone revenue saw a sharp sequential decline, dropping from Rs 48.40 Cr in the previous quarter to Rs 24.07 Cr.
Confidence: HIGH
What changedThe company has reported its first quarter results for FY27, showing strong year-on-year growth and a sharp recovery in profitability compared to the previous quarter.
Why it mattersThe results demonstrate the company's ability to scale its consumer healthcare platform and improve operating leverage, though the sharp sequential drop in standalone revenue warrants caution regarding revenue stability.
Consolidated Revenue (Q1 FY27): Rs 33.11 CrConsolidated PAT (Q1 FY27): Rs 1.42 CrYoY Revenue Growth: 46.3%QoQ PAT Growth: 150.8%Q1 Revenue vs TTM Revenue: ~21.4%
📅 Short termThe stock may see positive sentiment driven by the strong YoY top-line growth and the significant sequential recovery in net profit.
📈 Long termThe structural shift from a product-only model to a service-led wellness tourism model is the key long-term driver; success depends on the execution of the Rs 30 Cr planned investment.
⚠ Risk flags
- Zero promoter holding
- High sequential volatility in standalone revenue
- Reliance on third-party e-commerce platforms
- Significant client concentration in exports
Key Highlights
Consolidated revenue reached Rs 33.11 Cr, a 46.3% increase over the Rs 22.63 Cr reported in Q1 FY26.
Consolidated PAT stood at Rs 1.42 Cr, representing a 150.8% QoQ jump from Rs 0.56 Cr in the preceding quarter.
Standalone revenue of Rs 24.07 Cr accounts for approximately 73% of consolidated revenue, indicating growing subsidiary contributions.
Earnings Per Share (EPS) improved to Rs 0.29 from Rs 0.24 in the same quarter last year.
Standalone total expenses were managed at Rs 23.52 Cr against a total income of Rs 24.72 Cr.
👀 What to Watch
Investors should monitor the sustainability of the triple-digit QoQ profit growth and the execution of the Rs 30 Cr investment in wellness tourism centers, which is expected to contribute to revenue over the next 24 months.
